221 related articles for article (PubMed ID: 34617326)
1. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis.
Robles-Valero J; Fernández-Nevado L; Lorenzo-Martín LF; Cuadrado M; Fernández-Pisonero I; Rodríguez-Fdez S; Astorga-Simón EN; Abad A; Caloto R; Bustelo XR
EMBO J; 2021 Nov; 40(22):e108125. PubMed ID: 34617326
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma.
Cortes JR; Filip I; Albero R; Patiño-Galindo JA; Quinn SA; Lin WW; Laurent AP; Shih BB; Brown JA; Cooke AJ; Mackey A; Einson J; Zairis S; Rivas-Delgado A; Laginestra MA; Pileri S; Campo E; Bhagat G; Ferrando AA; Rabadan R; Palomero T
Cell Rep; 2022 Apr; 39(3):110695. PubMed ID: 35443168
[TBL] [Abstract][Full Text] [Related]
3. The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.
Morrish E; Wartewig T; Kratzert A; Rosenbaum M; Steiger K; Ruland J
Eur J Immunol; 2023 Mar; 53(3):e2250147. PubMed ID: 36541400
[TBL] [Abstract][Full Text] [Related]
4. VAV1 mutations contribute to development of T-cell neoplasms in mice.
Fukumoto K; Sakata-Yanagimoto M; Fujisawa M; Sakamoto T; Miyoshi H; Suehara Y; Nguyen TB; Suma S; Yanagimoto S; Shiraishi Y; Chiba K; Bouska A; Kataoka K; Ogawa S; Iqbal J; Ohshima K; Chiba S
Blood; 2020 Dec; 136(26):3018-3032. PubMed ID: 32992343
[TBL] [Abstract][Full Text] [Related]
5. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas.
Abate F; da Silva-Almeida AC; Zairis S; Robles-Valero J; Couronne L; Khiabanian H; Quinn SA; Kim MY; Laginestra MA; Kim C; Fiore D; Bhagat G; Piris MA; Campo E; Lossos IS; Bernard OA; Inghirami G; Pileri S; Bustelo XR; Rabadan R; Ferrando AA; Palomero T
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):764-769. PubMed ID: 28062691
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model.
Robles-Valero J; Fernández-Nevado L; Cuadrado M; Lorenzo-Martín LF; Fernández-Pisonero I; Abad A; Redín E; Montuenga L; Martín-Zanca D; Bigas A; Mallo M; Dosil M; Bustelo XR
Mol Oncol; 2022 Oct; 16(19):3533-3553. PubMed ID: 35895495
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol Monophosphates Regulate Optimal Vav1 Signaling Output.
Rodríguez-Fdez S; Citterio C; Lorenzo-Martín LF; Baltanás-Copado J; Llorente-González C; Corbalán-García S; Vicente-Manzanares M; Bustelo XR
Cells; 2019 Dec; 8(12):. PubMed ID: 31888228
[TBL] [Abstract][Full Text] [Related]
8. Lysine Acetylation Reshapes the Downstream Signaling Landscape of Vav1 in Lymphocytes.
Rodríguez-Fdez S; Fernández-Nevado L; Lorenzo-Martín LF; Bustelo XR
Cells; 2020 Mar; 9(3):. PubMed ID: 32143292
[TBL] [Abstract][Full Text] [Related]
9. CD147 inhibits the nuclear factor of activated T-cells by impairing Vav1 and Rac1 downstream signaling.
Ruiz S; Castro-Castro A; Bustelo XR
J Biol Chem; 2008 Feb; 283(9):5554-66. PubMed ID: 18160397
[TBL] [Abstract][Full Text] [Related]
10. Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma.
Fujisawa M; Sakata-Yanagimoto M; Nishizawa S; Komori D; Gershon P; Kiryu M; Tanzima S; Fukumoto K; Enami T; Muratani M; Yoshida K; Ogawa S; Matsue K; Nakamura N; Takeuchi K; Izutsu K; Fujimoto K; Teshima T; Miyoshi H; Gaulard P; Ohshima K; Chiba S
Leukemia; 2018 Mar; 32(3):694-702. PubMed ID: 28832024
[TBL] [Abstract][Full Text] [Related]
11. Remedial strategies in structural proteomics: expression, purification, and crystallization of the Vav1/Rac1 complex.
Brooun A; Foster SA; Chrencik JE; Chien EY; Kolatkar AR; Streiff M; Ramage P; Widmer H; Weckbecker G; Kuhn P
Protein Expr Purif; 2007 May; 53(1):51-62. PubMed ID: 17275330
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.
Lazer G; Pe'er L; Farago M; Machida K; Mayer BJ; Katzav S
J Biol Chem; 2010 Jul; 285(30):23075-85. PubMed ID: 20457609
[TBL] [Abstract][Full Text] [Related]
13. Vav1 GEF activity is required for T cell mediated allograft rejection.
Haubert D; Li J; Saveliev A; Calzascia T; Sutter E; Metzler B; Kaiser D; Tybulewicz VL; Weckbecker G
Transpl Immunol; 2012 Jun; 26(4):212-9. PubMed ID: 22456277
[TBL] [Abstract][Full Text] [Related]
14. A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia.
Robles-Valero J; Lorenzo-Martín LF; Menacho-Márquez M; Fernández-Pisonero I; Abad A; Camós M; Toribio ML; Espinosa L; Bigas A; Bustelo XR
Cancer Cell; 2017 Nov; 32(5):608-623.e9. PubMed ID: 29136506
[TBL] [Abstract][Full Text] [Related]
15. T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascade.
Ramgolam VS; DeGregorio SD; Rao GK; Collinge M; Subaran SS; Markovic-Plese S; Pardi R; Bender JR
PLoS One; 2010 Dec; 5(12):e14450. PubMed ID: 21206905
[TBL] [Abstract][Full Text] [Related]
16. Distinct functions of Vav1 in JNK1 activation in Jurkat T cells versus non-haematopoietic cells.
Kaminski S; Del Pozo MA; Hipskind RA; Altman A; Villalba M
Scand J Immunol; 2004 Jun; 59(6):527-35. PubMed ID: 15182247
[TBL] [Abstract][Full Text] [Related]
17. Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1.
Razidlo GL; Wang Y; Chen J; Krueger EW; Billadeau DD; McNiven MA
Dev Cell; 2013 Mar; 24(6):573-85. PubMed ID: 23537630
[TBL] [Abstract][Full Text] [Related]
18. Function of the nucleotide exchange activity of vav1 in T cell development and activation.
Saveliev A; Vanes L; Ksionda O; Rapley J; Smerdon SJ; Rittinger K; Tybulewicz VL
Sci Signal; 2009 Dec; 2(101):ra83. PubMed ID: 20009105
[TBL] [Abstract][Full Text] [Related]
19. The association of Sam68 with Vav1 contributes to tumorigenesis.
Lazer G; Pe'er L; Schapira V; Richard S; Katzav S
Cell Signal; 2007 Dec; 19(12):2479-86. PubMed ID: 17855053
[TBL] [Abstract][Full Text] [Related]
20. Vav1-mediated scaffolding interactions stabilize SLP-76 microclusters and contribute to antigen-dependent T cell responses.
Sylvain NR; Nguyen K; Bunnell SC
Sci Signal; 2011 Mar; 4(163):ra14. PubMed ID: 21386095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
